Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus

Background: Hepatitis B is the main infection of the injured liver for humans. Inflammation of the liver is caused by hepatitis viruses may lead to cirrhosis and hepatocellular carcinoma. The B-cell stimulatory factor 2 (BSF-2) is one of the cytokines that affect the regulation and differentiation o...

Full description

Bibliographic Details
Main Authors: Ali A. Dawood, Mahmood A. A. Altobje, Zeyad T. Alrassam
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2021-03-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2091
_version_ 1797197910983573504
author Ali A. Dawood
Mahmood A. A. Altobje
Zeyad T. Alrassam
author_facet Ali A. Dawood
Mahmood A. A. Altobje
Zeyad T. Alrassam
author_sort Ali A. Dawood
collection DOAJ
description Background: Hepatitis B is the main infection of the injured liver for humans. Inflammation of the liver is caused by hepatitis viruses may lead to cirrhosis and hepatocellular carcinoma. The B-cell stimulatory factor 2 (BSF-2) is one of the cytokines that affect the regulation and differentiation of the human immune response. Objective: this report aims to estimate the BSF-2, GPT, and GOT levels in patients’ serum with different stages of hepatitis B compared with healthy control. Methods: This study assessed 52 patients presumably with acute and chronic cases who have HBsAg positive. BSF-2 was detected using ELISA assay. Biochemical parameters were determined using kits of an automated analyzer. SPSS version-16 software was used for statistical analysis. Results: Acute hepatitis B patients had shown elevation in BSF-2 level more than of chronic hepatitis B. GPT and GOT levels elevated in the acute hepatitis group more than of the chronic hepatitis group. We reported a significant value between BSF-2, GOT, and GPT levels. We didn’t score an association between patient’s age and cases groups of hepatitis. Conclusion: our data confirmed increasing of BSF-2 levels with the increase of GOT level more than GPT level with acute hepatitis B. BSF-2, GPT and GOT levels are varied in different courses of acute and chronic HBV. We surmised that the elevation of BSF-2 levels designates liver injury of patients with acute HBV.
first_indexed 2024-03-08T05:48:08Z
format Article
id doaj.art-d08b5f1330c6481a8eed548316af0320
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2024-04-24T06:51:29Z
publishDate 2021-03-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-d08b5f1330c6481a8eed548316af03202024-04-22T13:07:46ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2021-03-01231879410.15789/1563-0625-EOB-20911362Elevation of BSF-2 Level in Serum of Patients with Hepatitis B VirusAli A. Dawood0Mahmood A. A. Altobje1Zeyad T. Alrassam2College of Medicine, University of MosulCollege of Medicine, University of MosulCollege of Medicine, University of MosulBackground: Hepatitis B is the main infection of the injured liver for humans. Inflammation of the liver is caused by hepatitis viruses may lead to cirrhosis and hepatocellular carcinoma. The B-cell stimulatory factor 2 (BSF-2) is one of the cytokines that affect the regulation and differentiation of the human immune response. Objective: this report aims to estimate the BSF-2, GPT, and GOT levels in patients’ serum with different stages of hepatitis B compared with healthy control. Methods: This study assessed 52 patients presumably with acute and chronic cases who have HBsAg positive. BSF-2 was detected using ELISA assay. Biochemical parameters were determined using kits of an automated analyzer. SPSS version-16 software was used for statistical analysis. Results: Acute hepatitis B patients had shown elevation in BSF-2 level more than of chronic hepatitis B. GPT and GOT levels elevated in the acute hepatitis group more than of the chronic hepatitis group. We reported a significant value between BSF-2, GOT, and GPT levels. We didn’t score an association between patient’s age and cases groups of hepatitis. Conclusion: our data confirmed increasing of BSF-2 levels with the increase of GOT level more than GPT level with acute hepatitis B. BSF-2, GPT and GOT levels are varied in different courses of acute and chronic HBV. We surmised that the elevation of BSF-2 levels designates liver injury of patients with acute HBV.https://www.mimmun.ru/mimmun/article/view/2091elisagptgotbsf-2hbsag
spellingShingle Ali A. Dawood
Mahmood A. A. Altobje
Zeyad T. Alrassam
Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus
Медицинская иммунология
elisa
gpt
got
bsf-2
hbsag
title Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus
title_full Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus
title_fullStr Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus
title_full_unstemmed Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus
title_short Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus
title_sort elevation of bsf 2 level in serum of patients with hepatitis b virus
topic elisa
gpt
got
bsf-2
hbsag
url https://www.mimmun.ru/mimmun/article/view/2091
work_keys_str_mv AT aliadawood elevationofbsf2levelinserumofpatientswithhepatitisbvirus
AT mahmoodaaaltobje elevationofbsf2levelinserumofpatientswithhepatitisbvirus
AT zeyadtalrassam elevationofbsf2levelinserumofpatientswithhepatitisbvirus